by
3.56 of 5 stars
When Sula overhears a shocking revelation about a drug being developed by her employer, she’s paralyzed with indecision. She desperately nee... read full description

reviews

Jun 26, 2011
Jacque rated it: 3 of 5 stars
Note: I received a free copy of this book in exchange for writing a review.

Main character Sula works for a pharmaceutical company. She eavesdrops on a conversation between the CEO and a company research scientist, revealing that the company's newest antidepressant is causing high rates of suicide in clinical trials. The CEO wants to keep this info under wraps, and the research scientist soon disappears. Due to her own history with depression and suicide in her family, Sula feels compel More...
0 comments like (1 person liked it)
Sep 08, 2010
Larry rated it: 4 of 5 stars
Times being what they are, most of us are on more medications than we'd like to think about. And there is big money in big pharma, to the tune of billions. With so much money in play, big greed is sure to be sniffing around.

Drugs have side-effects (have you watched a pharmaceutical commercial lately? One might almost be safer with the disease.), and, if serious enough, these can cause injury, death, recalls, and big losses. L. J. Sellers takes this situation to spin a tale of a wonde More...
0 comments like (1 person liked it)
Mar 19, 2011
Tara rated it: 2 of 5 stars
Could just be me... but I found this too hard to get into and not very thrilling for a thriller. It's a great premise, but it had so much other detail thrown in.. unneccesary details not related to the story line that I found myself skimming.

I don't need to know what kind of suit the man wears, nor what he did, where he ran, what he ate prior to the "big meeting." Also things were thrown in that had me scratching my head in confusion. Chicks boxing.. love it, but why is it More...
0 comments like (1 person liked it)
Mar 03, 2011
Elaine rated it: 4 of 5 stars
Sula works for a drug company who has developed a new antidepressant drug. While waiting to speak to them, she overhears the head of research and development, Doctor Warner and Rudker, the company's CEO arguing. Diane Warner wants to reveal to the merged company's new owners about suicides in the early trials of the new drug. The CEO gets angry and issues a threat to the doctor if this information leaks out. Sula is stunned by this news and as the meeting between the doctor and CEO breaks up More...
Nov 27, 2010
Kari rated it: 4 of 5 stars
Coming from a difficult past, Sula is finally achieving respectability. She works in the P.R. department for the pharmaceutical company, Prolabs, and is striving to regain custody of her small son.

But her plans are derailed when she discovers the company's new antidepressant drug, Nexapra, has proven fatal for some Hispanics involved in the drug study. She hopes someone higher up will come forward with this information, but after that proves to be impossible, Sula becomes involved More...
Oct 11, 2011
Theresa rated it: 5 of 5 stars
Mea culpa, THE SUICIDE EFFECT is only the second L. J. Sellers novel I have read. I’ve discovered that L. J. Sellers is a nearly perfect author for me.

In THE SUICIDE EFFECT the protagonist is someone I really like (this seems to be important to me). L. J. has made all her characters come alive; they do stupid stuff because of who they are, and L. J. has made me care about them.

THE SUICIDE EFFECT contains a truly fascinating Mind of the Killer (or Mind of the Bad Guy, I shoul More...
0 comments like (1 person liked it)
Jan 29, 2012
Hannah rated it: 4 of 5 stars
When I first started reading this book, I couldn't remember what the synopsis had said as it had been a while between downloading and reading. I soon remembered once I started reading, and suffering from depression and anxiety myself, which I am also medicated for I really liked the premise of this book. It had good pace, and wasn't too long or too short. It was definitely a page turner as it was a bit of a cat and mouse game at times, leaving you almost breathless with the sensation of being ch More...
Jan 24, 2012
Melissa rated it: 3 of 5 stars
I've never read a novel told from the pint of view of some many psychologically troubled individuals. Of the 6 characters that had viewpoints, 3 were on anti-depressants. Of those three, they had very different experiences. Oftentimes, we lump mental illness into one bin, but there is such a spectrum.
Feb 24, 2011
Carl rated it: 3 of 5 stars
For me, the book fell short of the author's Det. Jackson series, but was still enjoyable. The story unfolded well and progressed steadily, building suspense as each detail became more revealing to the reader. As the end of the tale closed, the author did a good job of closing the details of the side stories that went along with the main plot. I particularly enjoyed the character development of both the protagonist and the antagonist in the story. Recommended reading.
Dec 01, 2010
Darcy rated it: 4 of 5 stars
This book started out slow. I got about of 1/5 of the way through and it finally picked up. It was hard for me to put the book down. Time flew by so fast for me. The plot was great. It was full of suspense.

Rudker is such a pain in the ass. This guy has rude thoughts. It's hard to believe that Robbie is his son who he cares for. Rudker is one cold guy. He will go as far as to kill someone to get what he wants. We all knew he killed Dr. Warner who found out that his medication was flawe More...
Apr 08, 2011
Rick rated it: 5 of 5 stars
LJ Sellers is quickly becoming a new favorite of mine in the thriller genre. This book had it all: suspense, timeliness (it revolves around a pharmaceutical company bringing a new anti-depressant to market that could have disastrous consequences), and great unique and sympathetic characters.
0 comments like (2 people liked it)
Dec 21, 2011
Doreen rated it: 3 of 5 stars
Well written. Makes you stop and wonder about all of the clinical trials going on... It's a page turner and I found myself rooting for Sula. ( And conversely, definately not liking Rudker.)
Feb 15, 2011
Emily rated it: 4 of 5 stars
I had a harder time getting into this one vs. LJ's series of books, but once I hit around 10% or so, I was hooked. Great book!
Dec 29, 2011
Lindsay rated it: 3 of 5 stars
I liked this story, however, there were many typos and grammatical errors that irked me. it was a quick read.
0 comments like (1 person liked it)
Dec 24, 2011
Gerald rated it: 4 of 5 stars
1st book that I have read by this Author. It kept me intrested from the 1st page. I will look for more books by this author.
Nov 11, 2010
Rena marked it as to-read
I want to read/review this book soon.
Dec 31, 2011
Pen rated it: 2 of 5 stars
Second book of hers I have read and I won't be reading another. Interesting plot but does not tell the story well and doesn't hook the reader in.
Dec 19, 2011
Angie rated it: 3 of 5 stars
Despite the fact that this book was predictable, the pace was fast enough that I read it in a couple of days.
Nov 12, 2010
Mickey Hoffman rated it: 3 of 5 stars
Main idea: An evil drug company wants to put a drug on the market without finishing testing. I found it odd that almost everyone in the book seems to be taking anti-depressives or other psychotropic medication.
Didn't like this one nearly as much as her other books. All the typos didn't help and there
was a reference to someone logging on to Compuserve, which I think went bellyup as a company
in the mid 90s.
Nov 11, 2010
shinfu marked it as to-read
This looks like it will be a great book to read.
Jan 16, 2012
Ciara rated it: 2 of 5 stars
Very predictable!
Nov 11, 2010
Jeffrey marked it as to-read
I hope to read and review this book soon.
Oct 11, 2011
Jen rated it: 5 of 5 stars
A quick read but very very good. Story and plot were well written and I will be looking for the rest of her books to read.
Dec 16, 2011
Michelle V. added it
I just received my advanced copy, thanks! It's in my to-read pile perched precariously on the end table :).
Dec 07, 2011
Larry rated it: 4 of 5 stars
Very good book. Kept you reading long after bedtime.
Feb 20, 2012
Louise is currently reading it
Feb 19, 2012
Colette marked it as to-read
Feb 13, 2012
Rachel rated it: 4 of 5 stars
Feb 05, 2012
Nikki rated it: 2 of 5 stars
Feb 12, 2012
Beckie marked it as to-read